CommercialCoverageMedium impact
08.02.12b, Epcoritamab-bysp (EPKINLY®)
Independence Blue Cross·Pharmacy, Oncology·Pharmacy
Effective date
Mar 24, 2025
We identified it
Jun 19, 2026
Summary
Policy 08.02.12b for Epcoritamab-bysp (EPKINLY®) has been updated effective March 24, 2025, with changes to medical necessity criteria, medical coding, and general guidelines. This is a recent pharmacy policy affecting coverage and billing requirements for this medication. The billing team must review updated medical necessity criteria and ensure proper coding alignment in claims submission.
Action Required
By March 24, 2025: Billing team and pharmacy staff must review the complete policy text at the provided URL to identify specific medical necessity criteria updates, coding changes, and guidelines for Epcoritamab-bysp (EPKINLY®). Update billing system rules and prior authorization templates to reflect new medical necessity requirements. Providers must document medical necessity per updated criteria for all claims. Train front-end and back-end billing staff on any new prior authorization triggers or coding rules. Verify all claims submitted after March 24, 2025 comply with updated guidelines to prevent denials.